MONTREAL, December 22, 2017 - The World Anti-Doping Agency (WADA) has announced that it has reinstated its accreditation of the Laboratory of the Agence Française de lutte contre le Dopage (the National Anti-Doping Organization of France) in Châtenay-Malabry, France (Paris Laboratory). The Paris Laboratory is therefore able to resume all of its anti-doping activities, including the analysis of urine and blood samples, with immediate effect.
The decision to reinstate the Paris Laboratory’s WADA accreditation was based on a recommendation made by WADA’s Laboratory Expert Group, which was satisfied that the Laboratory successfully corrected the non-conformities with the International Standard for Laboratories (ISL) that the Paris Laboratory voluntarily reported to WADA. This resulted in the provisional suspension of the Laboratory’s WADA accreditation on 25 September 2017, followed by the imposition of a six month suspension on 31 October 2017.
“WADA is pleased to confirm that the Paris Laboratory’s accreditation has been reinstated,” said WADA Director General, Olivier Niggli. “We would like to commend the Laboratory for the cooperation and hard work that led to this quick reinstatement,” said Niggli. “We are confident that the Laboratory has corrected its deficiencies and our Laboratory Expert Group will now continue to monitor the Laboratory’s performance to ensure that it operates to the high standards required by WADA.”
According to the ISL, WADA is responsible for accrediting and re-accrediting anti-doping laboratories, thereby ensuring that they maintain the highest quality standards. This monitoring process is conducted in conjunction with International Organization for Standardization (ISO) assessment by independent national accreditation bodies that are full members of the International Laboratory Accreditation Cooperation (ILAC).